Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Beginning Cash Balance (2024)

BioCorRx's Beginning Cash Balance history spans 2 years, with the latest figure at $2000.0 for Q4 2024.

  • For Q4 2024, Beginning Cash Balance changed N/A year-over-year to $2000.0; the TTM value through Sep 2025 reached $11000.0, up 22.22%, while the annual FY2024 figure was $11000.0, 68.57% down from the prior year.
  • Beginning Cash Balance for Q4 2024 was $2000.0 at BioCorRx, down from $9000.0 in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $9000.0 in Q3 2024 and bottomed at $2000.0 in Q4 2024.